US3923603A - Discrete plasmid construction from chromosomal genes in pseudomonas - Google Patents
Discrete plasmid construction from chromosomal genes in pseudomonas Download PDFInfo
- Publication number
- US3923603A US3923603A US493691A US49369174A US3923603A US 3923603 A US3923603 A US 3923603A US 493691 A US493691 A US 493691A US 49369174 A US49369174 A US 49369174A US 3923603 A US3923603 A US 3923603A
- Authority
- US
- United States
- Prior art keywords
- pseudomonas
- genes
- plasmid
- strain
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 94
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 76
- 241000589516 Pseudomonas Species 0.000 title claims abstract description 42
- 230000002759 chromosomal effect Effects 0.000 title claims description 41
- 238000010276 construction Methods 0.000 title description 3
- 238000012546 transfer Methods 0.000 claims abstract description 48
- 230000003413 degradative effect Effects 0.000 claims abstract description 38
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 9
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 8
- 230000037361 pathway Effects 0.000 claims description 34
- 241000589776 Pseudomonas putida Species 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 16
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 9
- 230000015556 catabolic process Effects 0.000 claims description 8
- 238000006731 degradation reaction Methods 0.000 claims description 7
- 230000021615 conjugation Effects 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims description 3
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims description 3
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims description 3
- 241000320118 Pseudomonas putida PRS1 Species 0.000 claims 2
- 210000000349 chromosome Anatomy 0.000 abstract description 11
- 210000004027 cell Anatomy 0.000 description 29
- 108090000790 Enzymes Proteins 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 13
- 230000002068 genetic effect Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 108091008053 gene clusters Proteins 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101100193519 Caenorhabditis elegans qui-1 gene Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000007003 mineral medium Substances 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001483 mobilizing effect Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002463 transducing effect Effects 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 241000589781 Pseudomonas oleovorans Species 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000030414 genetic transfer Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- -1 mercury ions Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/82—Subcellular parts of microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/877—Pseudomonas putida
Definitions
- a transfer plasmid (factor K) is transferred from a first Pseudomonas organism to a second Pseudomonas organism.
- Factor K induces the mobilization of genes from the chromosome of the second Pseudomonas organism and under proper conditions will transfer the mobilized genes to a recipient organism in which those particular genes have been deleted.
- the factor K and the mobilized genes enter the recipient and become established there as stable separate plasmids constituting a plasmid aggregrate.
- Non-transmissible artificial hydrocarbon degradative plasmids have been created in Pseudomonas organisms in this manner and (with factor K present in the host to accomplish the transfer) have been transmitted to other Pseudomonas recipients.
- Plasmid A hereditary unit that is physically separate from the chromosome of the cell; the terms extrachromosomal element and plasmid are synonymous; when physically separated from the chromosome, some plasmids can be transmitted at high frequency to other cells;
- Transmissible plasmid A plasmid that carries genetic determinants for its own intercell transfer via conjugation
- Bacteriophage A particle composed of a piece of DNA encoded and contained within a protein head portion and having a tail and tail fibers composed of protein;
- Curing agent A chemical material or a physical treatment that enhances curing
- Degradative'pathway A sequence of enzymatic reactions (e.g. 5 to enzymes are produced by the microbe) converting the primary substrate to some simple common metabolite, a normal food substance for microorganisms;
- Replicon A genetic unit that enables a piece of DNA to undergo replication
- Auxotroph A mutant organism that requires a food source containing a particular amino acid or vitamin for growth;
- Plasmid Indicative of cells lacking in the designated plasmid or cells harboring a non-functional derivative of the given plasmid;
- amino-acid Indicative of a strain that cannot manufacture the designated amino acid
- OCT optical coherence tomography
- Plasmids are believed to consist of double-stranded 5 component of the host cell. Generally, plasmids are not essential for cell viability.
- Plasmids may be compatible (i.e. they can reside stably in the same host cell) or incompatible (i.e. they are unable to reside stably in a single cell).
- plasmids for example, are sex factor plasmids and drug-resistance plasmids.
- a Pseudomonas organism may have a desired capability of degrading some given complex organic compound, but this ca-. pability is of chromosomal origin. If it be desired to transfer the desired capability to a recipient cell by the techniques described in the patent, these techniques will not suffice.
- the process for transforming chromosomal 3. determine whether the specifying genes are plas-' mid-bome or are chromosomal; 4. if the desired degradative pathway is specified by the chromosome, introduce factor K into the cell by selection techniques and 5. use the cell so modified genetically to transfer the genes for the degradative pathway to a recipient Pseudomonas cell (factor K will, of course, also be transferred simultaneously), the recipient organism selected being one in which those particular genes have beendeleted.
- Recipient cells surviving growth on a minimal plate now contain the transmissible factor K and, separate therefrom (but constituting a plasmid aggregate therewith) the nontransmissible degradative pathway.
- Steps 1-5 can be repeated to in troduce multiple compatible plasmids into the same recipient. Also this process can be used to introduce an artificial plasmid into a Pseudomonas cell which already has one or more plasmids so long as the ultimate plasmid content is compatible.
- the development of cell capability in a single strain for the degradation and conversion of complex hydrocarbons can be extended for-even greater efficiency to cope with massive oil spills or engage in the production of protein.
- all that is necessary is that all the microorganisms providing these pathways be of the same strain in order to insure compatibility.
- the total complement of organisms all of the same strain may include a concentration of cells with four degradative plasmids and six concentrations of cells, each containing a different degradative pathway.
- P. putida PRSl K (NRRL B-8043) Derived from Pseudomonas putida PRSl (ATCC No. 12633) by genetic transfer thereto of a transfer plasmid (factor K) from Pseudomonas putida strain PpGl (ATCC No. 17453).
- a sub-culture of this strain can be obtained from the permanent collection of the Northern Marketing and Nutrient Research Division, Agricultural Service, U.S. Department of Agriculture, Peoria, 111., USA.
- factor K serving as a gene transfer vector in somewhat the same way as the F plasmid, the sex factor in E. coli.
- factor K could be used to mobilize chromosomal genes and transfer the mobilized genes to a recipient cell in which those particular genes have been deleted, the mobilized genes thereupon becoming stabilized in the recipient as a separate inheritable plasmid.
- Factor K is shown as being responsible for the transfer of the OCT plasmid and some chromosomal genes.
- the chromosomal genes so substituted became part of the chromosome of the recipient cell (recombinant) as contrasted to the formation of a conjugatant in the instant invention.
- the recipient cell is deliberately selected as one in which the genes for the given degradative pathway have been deleted and as a result the transferred chromosomal genes cannot undergo recombination with the recipient chromosome. These genes, therefore, replicate as a separate artificial plasmid.
- the compositions of the synthetic mineral media for growth of the cultures were the same for all the Pseudomonas species employed.
- the mineral medium was prepared from:
- P. putida PpGl does not have any region of genetic homology corresponding to the mdl and qui genes, an investigation was made to determine whether these gene clusters were integrated at some site on the PpGl chromosome or whether these genes would replil5 cate as autonomously-replicating genetic fragments (plasmids).
- Table 4 sets forth the mandelate enzyme levels (specific activities in nanomoles of substrate consumed or product formed per minute per mg of protein) in certain conjugatants of PRSl, PpGl and Md1 PpG1 strains.
- An assay of the mandelate enzymes was made according to the method outlined in the article Synthesis of the Enzymes of the Mandelate Pathway by Pseudomonas putida (J. Bacteriol. 91
- Curing degradative pathways from each strain with mitomycin C was accomplished by preparing several test tube ofL broth [Lennox, E. S. (1955), Virology, 1, ]containing varying concentrations of mitomycin C and inoculating these tubes with suitable dilutions of early stationary phase cells of the given strain to give concentrations 10 to 10 cells/ml. These tubes were incubated on a shaker at 32C for 2-3 days. Aliquots from tubes that showed some growth were then diluted and plated on glucose minimal plates. After growth at 32C for 24 hours, individual colonies were split and respotted on glucose-minimal and degradative pathway-minimal plates to give the proportion of MDL and QUI in order to determine the frequency of curing. It was, therefore, shown that in each instance the degradative pathway genes are plasmid-borne.
- mandelate negative cured derivatives when analyzed in the manner referred to above for the presence of mandelate enzymes, showed loss of all the mandelate enzymes, suggesting that curing leads to the loss of the entire gene clusters. This, in turn, indicates that these genes appear to replicate independently as plasmids.
- MDL mandelate plasmid
- AC 108 AC 10 Met 1 X 10' V (QUY'K) AC 10 QUl 1 x 1'0 AC 109 is a QUI transductant of Ac 10 from AC 107 as donor. Out of 10 transduct-ants tested none transferred either QUI or chromosomal markers.
- AC 110 is a Mitomycln C-induced QUl'segregant of AC 107. r
- AC 108 is a Trp'llv" recombinant of AC 20 which has acquired QUI but not factor K (donor used with AC 107).
- factor K in Pseudomonas when factor K is utilized to mobilize chromosomal genes and transfer them to a recipient from which the chromosomal genes being transferred were deleted, the mobilized genes and factor K take the form of a plasmid aggregrate.
- the presence of factor K assures transmissibility of the artifically created plasmids to other cells, although the frequency of transfer for such plasmids is usually 50-100 fold lower than that of most chromosomal genes, as would be expected.
- a Pseudomonas strain is identified and isolated that exhibits the capability for converting the primary substrate to some common metabolite (i.e. the organism exercises the requisite degradative pathy),
- the strain of Pseudomonas (different from the organism in step 2) actually to be used to accomplish the substrate degradation is selected, this strain being one in which the genes sepcifying the requisite degradative pathway are missing,
- the nature of the genes (in the organisms of step 2) specifying the requisite degradative pathway (e.g. plasmid-home or chromosomal) is determined; this is accomplished by curing and conducting independent conjugal transmissibility tests (if the capability for the specific degradative pathway is transferred, the degradative pathway is plasmid-home and transmissible in which case this invention is not needed; if the specific capability is not cured from the donor organism, factor K is employed by the exercise of the following steps:
- factor K introduce factor K into this strain by using an auxotrophic mutant of P. putida PRSl K as donor and the multiple auxotroph as recipient; selection is made for the repair of any one of the requirements of the recipient auxotrophs (about 50% of the recombinants will have acquired factor K); this is followed by purification of 10-12 recombinants by single colony isolation and sub sequent analysis for the presence of factor K;
- step 2 transfer the desired degradative pathway to the Pseudomonas isolated in step 2 using the auxotrophis recombinant harboring factor K as the donor; transfer is by conjugation in the manner 1 1 described in the Chakrabarty patent (column 7, lines lO-38 and d. purify the conjugatants; these conjugatants contain the desired degradative pathway in the form I of a plasmid that is non-transmissible in the absence of factor K.
- a process for transferring chromosomal genes specifying a hydrocarbon degradative pathway for a given substrate from a first strain of Pseudomonas and imparting said chromosomal genes as part of a plasmid aggregate into a second strain of Pseudomonas which does not contain said chromosomal genes comprising the steps of:
- putida PRSl and the second strain is P. putida PpGl.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A transfer plasmid (factor K) is transferred from a first Pseudomonas organism to a second Pseudomonas organism. Factor K induces the mobilization of genes from the chromosome of the second Pseudomonas organism and under proper conditions will transfer the mobilized genes to a recipient organism in which those particular genes have been deleted. The factor K and the mobilized genes enter the recipient and become established there as stable separate plasmids constituting a plasmid aggregrate. Non-transmissible artificial hydrocarbon degradative plasmids have been created in Pseudomonas organisms in this manner and (with factor K present in the host to accomplish the transfer) have been transmitted to other Pseudomonas recipients.
Description
United States Patent 1191 Chakrabarty et al.
[ Dec.2, 1975 DISCRETE PLASMID CONSTRUCTION FROM Cl-IROMOSOMAL GENES IN PSEUDOMONAS [75] Inventors: Ananda M. Chakrabarty, Latham;
Denise A. Friello, Schenectady, both of N.Y.
[73] Assignee: General Electric Company,
Schenectady, NY.
221 Filed: Aug. 1, 1974 211 App] No.: 493,691
[52] US. Cl 195/78; 195/30 [51] Int. Cl. C12B 1/00 [58] Field of Search 195/96, 28 R, 1, 3 H, 30,
[56] References Cited OTHER PUBLICATIONS Chakrabarty Dissociation of Degradative Plasmid Aggregate In Pseudomones" J. Bacteriol, 118, 815-820 (1974).
Primary ExaminerA. Louis Monacell Assistant Examiner-R. B. Fenland Attorney, Agent, or Firm-Jane M. Binkowski; Joseph T. Cohen; Jerome C. Squillaro [57] ABSTRACT A transfer plasmid (factor K) is transferred from a first Pseudomonas organism to a second Pseudomonas organism. Factor K induces the mobilization of genes from the chromosome of the second Pseudomonas organism and under proper conditions will transfer the mobilized genes to a recipient organism in which those particular genes have been deleted. The factor K and the mobilized genes enter the recipient and become established there as stable separate plasmids constituting a plasmid aggregrate. Non-transmissible artificial hydrocarbon degradative plasmids have been created in Pseudomonas organisms in this manner and (with factor K present in the host to accomplish the transfer) have been transmitted to other Pseudomonas recipients.
5 Claims, N0 Drawings DISCRETE PLASMID CONSTRUCTION FROM CHROMOSOMAL GENES IN PSEUDOMONAS BACKGROUND OF THE INVENTION The terminology of microbial genetics is sufficiently complicated that certain definitions will be particularly useful in the understanding of this invention:
Plasmid A hereditary unit that is physically separate from the chromosome of the cell; the terms extrachromosomal element and plasmid are synonymous; when physically separated from the chromosome, some plasmids can be transmitted at high frequency to other cells;
Transmissible plasmid A plasmid that carries genetic determinants for its own intercell transfer via conjugation;
DNA Deoxyribonucleic acid;
Bacteriophage A particle composed of a piece of DNA encoded and contained within a protein head portion and having a tail and tail fibers composed of protein;
Deletion The condition in which a substantial portion of the chromosomal DNA is missing;
Transducing phage A bacteriophage that carries fragments of bacterial chromosomal DNA and transfers this DNA on subsequent infection of another bacterium;
Conjugation The process by which a bacterium establishes cellular contact with another bacterium and the transfer of genetic material occurs;
Curing The process by which plasmids can be selectively eliminated from the microorganism;
Curing agent A chemical material or a physical treatment that enhances curing;
Degradative'pathway A sequence of enzymatic reactions (e.g. 5 to enzymes are produced by the microbe) converting the primary substrate to some simple common metabolite, a normal food substance for microorganisms;
Replication The process by which a piece of DNA divides itself into two identical copies;
Replicon A genetic unit that enables a piece of DNA to undergo replication;
Auxotroph A mutant organism that requires a food source containing a particular amino acid or vitamin for growth;
Recombinant A cell in which a portion of a genetic fragment has been substituted in the chromosome;
(Sole carbon source) --Indicative of a mutant incapable of growing on the given sole carbon source;
(Plasmid)" Indicative of cells from which the designated plasmid has been completely driven out by curing or in which no portion of the plasmid ever existed;
(Plasmid) Indicative of cells lacking in the designated plasmid or cells harboring a non-functional derivative of the given plasmid;
(Amino-acid) Indicative of a strain that cannot manufacture the designated amino acid;
(Vitamin) Indicative of a strain that cannot manufacture the designated vitamin and (Plasmid) Indicates that the cells contain the designated plasmid.
The symbol [OCT] as used herein signifies the plasmid aggregate composed of OCT, factor K and MER.
Plasmidsare believed to consist of double-stranded 5 component of the host cell. Generally, plasmids are not essential for cell viability.
Plasmids may be compatible (i.e. they can reside stably in the same host cell) or incompatible (i.e. they are unable to reside stably in a single cell). Among the known plasmids, for example, are sex factor plasmids and drug-resistance plasmids.
As is shown in U.S. Pat. No. 3,813,316 Chakrabarty the capability of some Pseudomonas species to degrade complex organic compounds is due to the presence of one or more transmissible plasmids, each of :which specifies the entire enzyme complement of a particular degradative pathway. Such plasmids are designated degradative plasmids. As is described in the Chakrabarty patent unique Pseudomonas organisms have been developed by transferring a number of such degradative pathways to the same recipient. However, the application of this genetic engineering technique has, heretofore, been limited to the transfer of, naturallyoccuring degradative plasmids. However, a Pseudomonas organism may have a desired capability of degrading some given complex organic compound, but this ca-. pability is of chromosomal origin. If it be desired to transfer the desired capability to a recipient cell by the techniques described in the patent, these techniques will not suffice.
It would be particularly advantageous to be able to transfer an entire enzyme complement of a particular degradative pathway, regardless of whetheror not a naturally-occurring degradative plasmid is available therefor.
DESCRIPTION OF THE INVENTION By the practice of the instant invention, once a Pseudomonas organism is found containing genes that specify the entire enzyme complement of a particular degradative pathway, if this pathway is not already plasmidborne, the requisite genes can now be transferred. This is accomplished by mobilizing these genes from the chromosome and transferring them to a preselected recipient in which these particular genes have been deleted. The transferred genes then become established therein as a separate stable artificial degradative plasmid. Mobilization of genes for subsequent transfer in this manner is accomplished by utilizing a transfer plasmid (factor K).
MANNER AND PROCESS OF MAKING AND USING THE INVENTION In brief, the process for transforming chromosomal 3. determine whether the specifying genes are plas-' mid-bome or are chromosomal; 4. if the desired degradative pathway is specified by the chromosome, introduce factor K into the cell by selection techniques and 5. use the cell so modified genetically to transfer the genes for the degradative pathway to a recipient Pseudomonas cell (factor K will, of course, also be transferred simultaneously), the recipient organism selected being one in which those particular genes have beendeleted. Recipient cells surviving growth on a minimal plate now contain the transmissible factor K and, separate therefrom (but constituting a plasmid aggregate therewith) the nontransmissible degradative pathway. Thereafter, the plasmid aggregate can be transferred to other recipient cell s. Steps 1-5 can be repeated to in troduce multiple compatible plasmids into the same recipient. Also this process can be used to introduce an artificial plasmid into a Pseudomonas cell which already has one or more plasmids so long as the ultimate plasmid content is compatible.
By the practice of this invention the development of cell capability in a single strain for the degradation and conversion of complex hydrocarbons can be extended for-even greater efficiency to cope with massive oil spills or engage in the production of protein. Thus, for example, if a total of degradative pathways are required for the efficient breakdown of a given crude oil, all that is necessary is that all the microorganisms providing these pathways be of the same strain in order to insure compatibility. The total complement of organisms all of the same strain may include a concentration of cells with four degradative plasmids and six concentrations of cells, each containing a different degradative pathway.
To facilitate the practice of this invention in the best mode contemplated, a culture of microorganisms possessing the transfer plasmid, factor K, is now on deposit with the United States Department of Agriculture. This culture is identified as follows:
P. putida PRSl K (NRRL B-8043) Derived from Pseudomonas putida PRSl (ATCC No. 12633) by genetic transfer thereto of a transfer plasmid (factor K) from Pseudomonas putida strain PpGl (ATCC No. 17453).
A sub-culture of this strain can be obtained from the permanent collection of the Northern Marketing and Nutrient Research Division, Agricultural Service, U.S. Department of Agriculture, Peoria, 111., USA.
Morphological observations in various media, growth in various media, general group characterization tests, utilization of sugars and optimum growth conditions for the strains from which the above-identified organisms were derived are set forth in The Aerobic Pseudomonads: A Toxonomic Study" by Stanier, R. Y. et al. [Journal of General Microbiology 43, pp. 159-271 1966) The taxonomic properties of the above-identified organisms remain the same as those of the parent strains. P. putida strain PpGl (ATCC No. 17453) is the same as strain 77 in the Stanier et al. study.
All the organisms referred to herein are non-pathogenic as is the general case with laboratory strains of Pseudomonas.
The capability for creating plasmid structures from chromosomal genes has been made possible by two discoveries. First, was the discovery that there exists for the Pse udomonas species a transfer plasmid, factor K, serving as a gene transfer vector in somewhat the same way as the F plasmid, the sex factor in E. coli. Next, was the discovery that factor K could be used to mobilize chromosomal genes and transfer the mobilized genes to a recipient cell in which those particular genes have been deleted, the mobilized genes thereupon becoming stabilized in the recipient as a separate inheritable plasmid.
Demonstration is given in the publication Dissociation of a Degradative Plasmid Aggregrate in Pseudomonas by A. M. Chakrabarty (J. Bacteriol. l 18 815820, 1974) that the transfer of the [OCT] plasmid from P. oleovorans to P. putida strain PpGl results in the acquisition by the recipient of three independent replicons: OCT (a non-transmissible plasmid specifying enzymes of the octane degradative pathway); MER (a transmissible plasmid, which confers resistance to high concentration of mercury ions) and factor K (the transfer plasmid). Factor K is shown as being responsible for the transfer of the OCT plasmid and some chromosomal genes. The chromosomal genes so substituted became part of the chromosome of the recipient cell (recombinant) as contrasted to the formation of a conjugatant in the instant invention. In this invention, however, the recipient cell is deliberately selected as one in which the genes for the given degradative pathway have been deleted and as a result the transferred chromosomal genes cannot undergo recombination with the recipient chromosome. These genes, therefore, replicate as a separate artificial plasmid.
The compositions of the synthetic mineral media for growth of the cultures were the same for all the Pseudomonas species employed. The mineral medium was prepared from:
PA Concentrate:
m1. of 1 molar K I-lPO 50 ml. of 1 molar KH PO ml. of 1 molar Nl-l Cl 100 X Salts:
19.5 gm. MgSO 5.0 gm. MnSO .l-I O 5.0 gm. FeSO .7l-1 O 0.3 gm. CaCl .2H O
1.0 gm. ascorbic acid 1 liter H O Each of the above (PA Concentrate and 100 X Salts) was sterilized by autoclaving. Thereafter, one liter of the mineral medium was prepared as follows:
PA Concentrate 77.5 ml.
100 X Salts 10.0 ml.
Agar 15.0 gm.
H O to one liter (the pH is adjusted to 6.8 7.0). All experiments were carried out at 32C unless otherwise stated.
For experiments in the transfer of factor K a strain of P. putida PRSl was selected. The biochemical and enzymological characterization of the several aromatic degradative pathways discussed herein and transductional genetic analyses thereof has been set forth in the literature [Ornston, L. N. 1971. Regulation of Catabolic Pathways in Pseudomonas. Bacteriol. Rev. 35 87-116]. The origin, derivation and phenotypes of P. putida strains and their mutants used in this work are set forth in Table 1.
TABLE l-continued mutants as shown in Table 2, equal volumes of overnight-grown (about 2-3 X cells/ml) cells of the 2;? donor (Met, OCT, K organisms and the respective griginal recipient organisms were mixed together and kept in a esi- Source or 5 gnation work Phenotypg Derivation stationary condltlon for 1 hour. Allquots of 0.1 ml were then plated on glucose-m1n1mal, or benzo1c-m1n1mal 2% $5 37 *AC 30 plates to score for chromosomal recombinants. AC 75 y n: oCT **AC 4 -+AC 9 TABLE 2 AC g f MDL+Y 28 3 10 l I Marker Frequenfcy of AC 107 Met: 0UP AC H7 Donor Rec1p1ent Selected Trans er AC 10 AC 75 AC 72 Ben 2 X 10-" AC 108 PE fl MAC (ocr ,1 Met) (Ilv', Ben) QUI AC 2 AC 72 11v 1 X 10' AC 109 Met, our gg 1187- lt vg. Ben) T 2 l0 7 X r AC 110 Met, K ****AC 107 15 (Try) W Put1da AC 105 1115* 5 X 10- PRSl WT m PRSZ AC 73 Mdl *PRSl AC 123 His* 2 x 10- PRS2158 AC 72 11v-, Ben *PRSl (His: our AC 74 llv, Ben **AC 75 Nic' 3 AC 72 AC 123 Ben* 1 10" PRS33l AC 78 Trp" *PRSl (Ben: PRS6O AC 79 Ben *PRSl Q Nic) AC 105 His *PRSl AC 116 llv Ben, **AC 75---) 1 AC 72 AC 21" 2g 5" This work (Table 2) has shown that factor K is inpMw159 AC 123 His-i our, p w 85 25 deed capable of mobilizing and transferring chromo- N B r AC 124 851+, AC 4* somal genes from one stram of Pseudomonas to an Qui-y AC 123 other strain and the resulting recombinants appear to be stable. About 50-80% of such recombinants acquire Treatment of Source or Derivation: tNflemymmmomitwmuanidinc factor K, thus 1nher1t1n g donorab1l1ty of chromosomal j gation genes to other suitable recipients making possible the *Qili fg 2:35:22 cufing transfer of factor K to dlfferent strains of Pseudomonas. The effort was made on two occasions to transfer bb chromosomal genes and thus factor K from P. putida A revlatlons employed are as follows' I Wlld strain PpGl to P. aeruginosa strain PAO without suczi i 82 qumate MDL cess. However, this is believed not to be insurmount- 6 T octaPer Q Trp ",YP- able and additional attempts will be made with restrictophan, Met meth1on1ne, Ilv --1soleuc1ne and vahne tion negative mutants of P aemgl-nosa FAQ and H18 hlstldme- The results of conjugational transfer of mandelate Fund Stfam PMW 15 9 descnbed the amcle and quinate genes mediated by factor K are shown in The Clustermg on the Pseudomonas putzda Chromo- 40 Table TABLE 3 Conjugatant Donor Recipient Selected Frequency Phenotype AC 116 AC 30 Mdl 3 X io- Manon- (K*llv*Ben) (PpGl WT) AC l0(Met) Met 2 X l0 Met Mdl'Qui AC 10 Md!" 5 x 10- Mdl Met'Qui(40%) AC 117 Md1 Mer*Qui-(%) (llv'Ben 'K AC 30 Qui 1 x 10' QuPMdl AC 10 our 1 x 10- Qui Mct'Mdl'(30%) Qui Met* AC 10 Met*' 4 x 10- MevQui-Mdr AC 73 Mdl 2 x 10-5 Mdl AC 78 Trp l X 10 Trp AC 79 Ben 1 X 10 Ben" AC 1415* 2 x 10- His AC 123 His* 5 X 10' His Ben'QuiNie AC 123 Ben 4 X 10' HisBenOuiNic' some of Genes Specifying Dissimilatory Functions Leidigh et al. (J. Molec. Evolution 2 235-242, 1973).
Two P. putida PRSl chromosomal recombinants are In Table l the phenotypes of known plasmids have 60 shown therein as genetic donors. It is known from the been capitalized, while those of the chromosomal genes are designated in lower case letters.
The results of determining the ability of factor K to mobilize chromosomal genes is shown in Table 2 wherein auxotrophic mutants of P. putida PRSl are used as recipients. Y
In carrying out the chromosomal genes transferfrom strain PpGl to a variety of strain PRSl auxotrophic literature that the genes specifying enzymes involved in the degradation of D or L mandelate by P. putida PRSl are totally absent in P. putida PpGl. Similarly, P. putida PpGl lacks some genes which specify enzymes for quinate metabolism. All Mdl PpGl conjugatants obtained were Qui while all Qui conjugatants obtained were Mdl". Co-transfer of these two (mdl and qui) gene clusters has not as yet been observed.
bers from strain PRSl to strain PpGl. 10
Since P. putida PpGl does not have any region of genetic homology corresponding to the mdl and qui genes, an investigation was made to determine whether these gene clusters were integrated at some site on the PpGl chromosome or whether these genes would replil5 cate as autonomously-replicating genetic fragments (plasmids). Table 4 sets forth the mandelate enzyme levels (specific activities in nanomoles of substrate consumed or product formed per minute per mg of protein) in certain conjugatants of PRSl, PpGl and Md1 PpG1 strains. An assay of the mandelate enzymes was made according to the method outlined in the article Synthesis of the Enzymes of the Mandelate Pathway by Pseudomonas putida (J. Bacteriol. 91
The enzyme level designations in Table 4 suggest that the mandelate genes are expressed normally inside strain PpGl (after transfer thereto of the mdl gene clusters from strain PRSl) and that the number of copies of such genes in both strains PRSl (AC 78) and Mdl PpGl (AC 104) is presumably the same.
Curing degradative pathways from each strain with mitomycin C was accomplished by preparing several test tube ofL broth [Lennox, E. S. (1955), Virology, 1, ]containing varying concentrations of mitomycin C and inoculating these tubes with suitable dilutions of early stationary phase cells of the given strain to give concentrations 10 to 10 cells/ml. These tubes were incubated on a shaker at 32C for 2-3 days. Aliquots from tubes that showed some growth were then diluted and plated on glucose minimal plates. After growth at 32C for 24 hours, individual colonies were split and respotted on glucose-minimal and degradative pathway-minimal plates to give the proportion of MDL and QUI in order to determine the frequency of curing. It was, therefore, shown that in each instance the degradative pathway genes are plasmid-borne.
Several of the mandelate negative cured derivatives, when analyzed in the manner referred to above for the presence of mandelate enzymes, showed loss of all the mandelate enzymes, suggesting that curing leads to the loss of the entire gene clusters. This, in turn, indicates that these genes appear to replicate independently as plasmids.
Further proof for establishing the plasmid nature of mdl and gui gene clusters in P. putida PpGl (to which these geneshave been transferred from strain PRSl) is the high rate of transmissibility of such genes to other suitable recipients. The capability for transfer of chromosomal genes and MDL and QUI plasmids is shown in Table 6. The AC 104 organism, which was a Met mutant of strain PpGl that had received the mandelate ge- Table 5 above sets forth the result of curing of MDL netic region from strain PRSl, proved to be a potent and QUI plasmids from P. putida PpGl strains. Neither 5O donor for chromosomal markers as well as for mdl of these degradative pathways are curable from strain genes.
TABLE 6 Transfer Conjugatant Donor Recipient Select Frequency Phenotype PRSl. However, both the mandelate and quinate genes in the PpGl conjugatants (AC 104 and AC 107) can be cured at a very low frequency.
Several chromosomal recombinants (selection on glucose-minimal) acquired the mandelate plasmid (MDL) by secondary infection. Transfer of the MDL plasmid (selection on mandelate-minimal supplemented with from the K PRSl strain (AC 116, Table 3) to PpGl recipient was accompanied by a simultaneous transfer of factor K to the respective recipient.
Autonomous replication of mdl and qui genes as plasmids in strain PpGl was verified by transfer of such plasmids by transduction. Transducing phage, pf 16, is known to be effective for the transfer of plasmids between organisms of strain PpGl [Genetic Basis of the Biodegradation of Salicylate in Pseudomonas Chakrabarty (J. Bacteriol. 112 815-823, 1972)]. Table 7 shows the results of transductional transfer of both MDL and QUI plasmids to PpGl cells deleted for these genes. Transductants were selected on mandelate and quinate-minimal plates supplemented with required amino acids. Unlike conjugational transfer, there was no associated transfer of chromosomal genes during transduction of such plasmids. The transductants harbor the mdl or qui gene clusters as plasmids, since they can be cured as explained hereinabove from the transductants at low frequency. Unlike the conjugatants, however, the MDL or the QUI transductants are incapable of transferring the MDL or QUI plasmids by conjugation to other recipients.
Results set forth in Table 8 below indicate that P. putida PpGl auxotrophic mutant AC 110, which is a QUI segregant of AC 107, still retains the donorability for chromosomal markers. This suggests that factor K was still present in the AC 110 organism, which had been cured of the QUI plasmid. However, AC 109, which had received the QUI plasmid from AC 107 by transduction, could not transfer either chromosomal genes or the QUI plasmid. Thus, QUI plasmid appeared to be non-transmissible, per se, and any transmission thereof, was because of the presence of factor K.
This conclusion is further supported by examination of the characteristics of a number of chromosomal recombinants using AC 107 as a donor. As noted in Table 6, 4-5% of chromosomal recombinants inherited the QUI plasmid under the conditions employed while nearly 50% of the chromosomal recombinants inherited the donorability. However, recombinants that acquire the QUl plasmid may or may not inherit factor K. AC 108, a recombinant, which had inherited QUl but not factor K was incapable (less than 1 X 10" transfer frequency) of transferring either chromosomal genes or the QUI plasmid to suitable recipients. However, if factor K were to be introduced into organism AC 108, this transfer plasmid would enable AC 108 to act as a donor for both QUI and other chromosomal genes. Thus, the presence of factor K is essential for the mobilization of QUI as well as the chromosome. Data for gansmissibility of the MDL plasmid was the same as for TABLE 8 Marker Transfer Donor Recipient Selected Frequency AC 107 AC 2 'lrp 4X 10: QUI K our 2 x 10- AC 109" AC 2 Trp 1 X 10" (QUPK') QUI 1 x 10"? J AC AC 2 Trp 2 X 10' (QUI'K*) QUP 1 X 10". AC 108 AC 10 Met 1 X 10' V (QUY'K) AC 10 QUl 1 x 1'0 AC 109 is a QUI transductant of Ac 10 from AC 107 as donor. Out of 10 transduct-ants tested none transferred either QUI or chromosomal markers.
AC 110 is a Mitomycln C-induced QUl'segregant of AC 107. r
AC 108 is a Trp'llv" recombinant of AC 20 which has acquired QUI but not factor K (donor used with AC 107). r
in Pseudomonas when factor K is utilized to mobilize chromosomal genes and transfer them to a recipient from which the chromosomal genes being transferred were deleted, the mobilized genes and factor K take the form of a plasmid aggregrate. The presence of factor K assures transmissibility of the artifically created plasmids to other cells, although the frequency of transfer for such plasmids is usually 50-100 fold lower than that of most chromosomal genes, as would be expected.
In the best mode contemplated for the practice of this invention, therefore:
1. the primary substrate to be degraded is determined,
2. a Pseudomonas strain is identified and isolated that exhibits the capability for converting the primary substrate to some common metabolite (i.e. the organism exercises the requisite degradative pathy),
3. the strain of Pseudomonas (different from the organism in step 2) actually to be used to accomplish the substrate degradation is selected, this strain being one in which the genes sepcifying the requisite degradative pathway are missing,
4. the nature of the genes (in the organisms of step 2) specifying the requisite degradative pathway (e.g. plasmid-home or chromosomal) is determined; this is accomplished by curing and conducting independent conjugal transmissibility tests (if the capability for the specific degradative pathway is transferred, the degradative pathway is plasmid-home and transmissible in which case this invention is not needed; if the specific capability is not cured from the donor organism, factor K is employed by the exercise of the following steps:
a. prepare a multiple auxotrophic mutant in the strain harboring the degradative pathway to be transferred as described in the textbook, Genetics of Bacteria and Their Viruses by William Hays [John Wiley & Sons, Inc. (1965)];
b. introduce factor K into this strain by using an auxotrophic mutant of P. putida PRSl K as donor and the multiple auxotroph as recipient; selection is made for the repair of any one of the requirements of the recipient auxotrophs (about 50% of the recombinants will have acquired factor K); this is followed by purification of 10-12 recombinants by single colony isolation and sub sequent analysis for the presence of factor K;
c. transfer the desired degradative pathway to the Pseudomonas isolated in step 2 using the auxotrophis recombinant harboring factor K as the donor; transfer is by conjugation in the manner 1 1 described in the Chakrabarty patent (column 7, lines lO-38 and d. purify the conjugatants; these conjugatants contain the desired degradative pathway in the form I of a plasmid that is non-transmissible in the absence of factor K.
Herein where reference is made to the quinic pathway it should be noted that this pathway applies for both quinic acid and p-hydroxybenzoic acid.
What we claim as new and desire to secure by Letters Patent of the US. is: Y
1. A process for transferring chromosomal genes specifying a hydrocarbon degradative pathway for a given substrate from a first strain of Pseudomonas and imparting said chromosomal genes as part of a plasmid aggregate into a second strain of Pseudomonas which does not contain said chromosomal genes comprising the steps of:
12 a. introducing factor K, a transfer plasmid, into at least one organism of said first strain of Pseudomonas which mobilizes said chromosomal genes and forms a plasmid aggregate therewith,
b. admixing the resulting first strain of Pseudomonas with said second strain of Pseudomonas transferring said plasmid aggregate by conjugation,
c. placing the mixture on minimal plates containing said given substrate as the sole source of carbon and d. purifying the resulting conjugatants.
2. The process of claim 1 wherein the source of factor K is P. putida PRSl K".
3. The process of claim 1 wherein the hydrocarbon pathway is for quinic acid degradation.
4. The process of claim 1 wherein the hydrocarbon degradative pathway is for mandelate degradation.
5. The process of claim 1 wherein the first strain is P.
putida PRSl and the second strain is P. putida PpGl.
Claims (5)
1. A PROCESS FOR TRANSFERRING CHROMOSOMAL GENES SPECIFYING A HYDROCARBON DEGRADATIVE PATHWAY FOR A GIVEN SUBSTRATE FROM A FIRST STRAIN OF PSEUDOMONAS AND IMPARTING SAID CHROMOSOMAL GENES AS PART OF A PLASMID AGGREGATE INTO A SECOND STRAIN OF PSEUDOMONAS WHICH DOES NOT CONTAIN SAID CHROMOSOMAL GENES COMPRISING THE STEPS OF: A. INTRODUCING FACTOR K, A TRANSFER PLASMID, INTO AT LEAST ONE ORGANISM OF SAID FIRST STRAIN OF PSEUDOMONAS WHICH MOBILIZED SAID CHROMOSOMAL GENES AND FORMS A PLASMID AGGREGATE THEREWITH, B. ADMIXING THE REUSLTING FIRST STRAIN OF PSEUDOMONAS WITH SAID SECOND STRAIN OF PSEUDOMONAS TRANSFERRING SAID PLASMIDE AGGREGATE BY CONJUGATION, C. PLACING THE MIXTUE ON MINIMAL PLATES CONTAINING SAID GIVEN SUBSTRATE AS THE SOLE SOURCE OF CARBON AND D. PURIFYING THE RESULTING CONJUGATANTS.
2. The process of claim 1 wherein the source of factor K is P. putida PRS1 K .
3. The process of claim 1 wherein the hydrocarbon pathway is for quinic acid degradation.
4. The process of claim 1 wherein the hydrocarbon degradative patHway is for mandelate degradation.
5. The process of claim 1 wherein the first strain is P. putida PRS1 and the second strain is P. putida PpG1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US493691A US3923603A (en) | 1974-08-01 | 1974-08-01 | Discrete plasmid construction from chromosomal genes in pseudomonas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US493691A US3923603A (en) | 1974-08-01 | 1974-08-01 | Discrete plasmid construction from chromosomal genes in pseudomonas |
Publications (1)
Publication Number | Publication Date |
---|---|
US3923603A true US3923603A (en) | 1975-12-02 |
Family
ID=23961301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US493691A Expired - Lifetime US3923603A (en) | 1974-08-01 | 1974-08-01 | Discrete plasmid construction from chromosomal genes in pseudomonas |
Country Status (1)
Country | Link |
---|---|
US (1) | US3923603A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352886A (en) * | 1981-01-27 | 1982-10-05 | Sybron Corporation | Process for treating wastewater containing phenolics and microorganism capable of degrading phenolics |
US4371615A (en) * | 1979-05-23 | 1983-02-01 | Ajinomoto Company Incorporated | Method for stabilizing the characteristics of microorganism containing a plasmid |
US4447539A (en) * | 1981-01-27 | 1984-05-08 | Sybron Corporation | Microorganism capable of degrading phenolics |
US4452894A (en) * | 1981-10-09 | 1984-06-05 | Microlife Genetics, Inc. | Pseudomonas compositions |
US4493895A (en) * | 1981-09-24 | 1985-01-15 | Occidental Chemical Corporation | Microbial degradation of obnoxious organic wastes into innocuous materials |
US4511657A (en) * | 1982-05-25 | 1985-04-16 | Occidental Chemical Corporation | Treatment of obnoxious chemical wastes |
US4584274A (en) * | 1983-02-09 | 1986-04-22 | The Regents Of The University Of California | Bacteriophage-resistant plant growth promoting rhizobacteria |
US4753876A (en) * | 1984-03-21 | 1988-06-28 | Monsanto Company | Marker genes in pseudomonad bacteria |
US4966841A (en) * | 1987-05-22 | 1990-10-30 | The Board Of Regents Of The University Of Washington | Enhanced vector production and expression of recombinant DNA products |
-
1974
- 1974-08-01 US US493691A patent/US3923603A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
Chakrabarty "Dissociation of Degradative Plasmid Aggregate In Pseudomones" J. Bacteriol, 118, 815-820 (1974) * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4371615A (en) * | 1979-05-23 | 1983-02-01 | Ajinomoto Company Incorporated | Method for stabilizing the characteristics of microorganism containing a plasmid |
US4352886A (en) * | 1981-01-27 | 1982-10-05 | Sybron Corporation | Process for treating wastewater containing phenolics and microorganism capable of degrading phenolics |
US4447539A (en) * | 1981-01-27 | 1984-05-08 | Sybron Corporation | Microorganism capable of degrading phenolics |
US4493895A (en) * | 1981-09-24 | 1985-01-15 | Occidental Chemical Corporation | Microbial degradation of obnoxious organic wastes into innocuous materials |
US4452894A (en) * | 1981-10-09 | 1984-06-05 | Microlife Genetics, Inc. | Pseudomonas compositions |
US4511657A (en) * | 1982-05-25 | 1985-04-16 | Occidental Chemical Corporation | Treatment of obnoxious chemical wastes |
US4584274A (en) * | 1983-02-09 | 1986-04-22 | The Regents Of The University Of California | Bacteriophage-resistant plant growth promoting rhizobacteria |
US4753876A (en) * | 1984-03-21 | 1988-06-28 | Monsanto Company | Marker genes in pseudomonad bacteria |
US4966841A (en) * | 1987-05-22 | 1990-10-30 | The Board Of Regents Of The University Of Washington | Enhanced vector production and expression of recombinant DNA products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tam et al. | Isolation and characterization of an s-ethyl-N, N-dipropylthiocarbamate-degrading Arthrobacter strain and evidence for plasmid-associated s-ethyl-N, N-dipropylthiocarbamate degradation | |
Olsen et al. | Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome | |
Bertram et al. | Natural transfer of conjugative transposon Tn916 between gram-positive and gram-negative bacteria | |
Smalla et al. | Exogenous isolation of antibiotic resistance plasmids from piggery manure slurries reveals a high prevalence and diversity of IncQ-like plasmids | |
Eaton et al. | Characterization of a plasmid-specified pathway for catabolism of isopropylbenzene in Pseudomonas putida RE204 | |
US3813316A (en) | Microorganisms having multiple compatible degradative energy-generating plasmids and preparation thereof | |
Chakrabarty et al. | Genetic regulation of octane dissimilation plasmid in Pseudomonas | |
Ronchel et al. | Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation | |
Donohue et al. | [22] Genetic techniques in rhodospirillaceae | |
Au et al. | Cloning of the cyo locus encoding the cytochrome o terminal oxidase complex of Escherichia coli | |
US4499189A (en) | Bacteria carrying plasmid having temperature dependent plasmid copy number | |
Oultram et al. | Conjugal transfer of plasmid pAMβ1 from Streptococcus lactis and Bacillus subtilis to Clostridium acetobutylicum | |
Lyras et al. | Conjugative Transfer of RP4-oriTShuttle Vectors fromEscherichia colitoClostridium perfringens | |
JPS5828277A (en) | Microorganism | |
US4626504A (en) | DNA transfer vector for gram-negative bacteria | |
US4680264A (en) | Class II mobilizable gram-negative plasmid | |
US3923603A (en) | Discrete plasmid construction from chromosomal genes in pseudomonas | |
Hardman et al. | Large plasmids from soil bacteria enriched on halogenated alkanoic acids | |
Jörg Kunte et al. | Transposon mutagenesis in halophilic eubacteria: conjugal transfer and insertion of transposon Tn5 and Tn 1732 in Halomonas elongata | |
Keshavarz et al. | Stability of a catabolic plasmid in continuous culture | |
Pappas et al. | Transposon mutagenesis and strain construction in Zymomonas mobilis | |
Dabbs et al. | Nocardioform arsenic resistance plasmids and construction of Rhodococcus cloning vectors | |
Paget et al. | Development of engineered genomic DNA to monitor the natural transformation of Pseudomonas stutzeri in soil-like microcosms | |
EP0213898B1 (en) | A host-vector system | |
US4686184A (en) | Gene transfer vector |